Bristol Myers Squibb launches Kopozgo (Mavacamten) in India for obstructive hypertrophic…
Kopozgo is the first and only oral cardiac myosin inhibitor approved in India for treating adults with symptomatic obstructive…
Author
New GMP standards in India expose fault line between regulators and MSMEs: GlobalData
GlobalData report highlights MSME concerns over India’s revised GMP and bio-equivalence mandates, warning that rapid enforcement…
GSK’s Nashik plant receives global BSI AMR Kitemark certification
Certification recognises GSK’s adherence to international standards for antibiotic manufacturing and commitment to antimicrobial…
Torrent Group’s UNM Foundation opens ‘Sankalan’ neuro rehab centre in Ahmedabad
The 30,000-square-foot Sankalan facility aims to provide integrated neuro rehabilitation care to underprivileged patients,…
The high cost of compromise: Why patient safety must come first
Dr Ranjit Barshikar, CEO – QbD International, United Nations Advisor cautions that India’s reputation as the ‘Pharmacy of the…
Natco to launch generic of Risdiplam for SMA patients
The company said it will launch the product immediately, with MRP of ₹15,900
Jubilant HollisterStier launches high-speed isolator based line at Spokane facility in US
This $132 million investment brings an additional 50 per cent capacity at its Spokane manufacturing facility
NSF, IDMA sign MoU to improve cGMP framework for India’s nutra industry
As per the MoU, NSF and IDMA will develop a tailored cGMP framework for Indian FBOs based on best global practices
Deal value increased by 320 per cent in September 2025, compared to September 2024
Three major deals contributed 79.7 per cent of the total deal value during September 2025
Lupin launches strategic partnership program to expand reach of its long-acting injectable platform
Following U.S. FDA approval for the first product using PrecisionSphere, Lupin’s new initiative aims to collaborate with global…